Metastatic Bladder Cancer — Rapid Case Review Issue 6
Featuring perspectives from Prof Yohann Loriot, including the following topics:
- Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related adverse events requiring steroids and then develops neuropathy due to EV — Nazli Dizman, MD (0:00)
- Case: A man in his early 70s with diabetes who received adjuvant nivolumab for FGFR3-mutant metastatic urothelial cancer receives first-line EV monotherapy and experiences hyperglycemia and cancer progression, then receives erdafitinib and experiences elevated phosphase, Grade 2 diarrhea and stomatitis and eventual disease progression — Jacqueline T Brown, MD (7:00)
- Case: A man in his late 80s with mUBC receives first-line EV/pembrolizumab and develops pneumonitis — Fern Anari, MD (17:40)
You May Also Like

Eye On The Sky
Vermont Public

Мослекторий
Москва 24

Arroe Collins Forest Stories
Arroe Collins

Science & Futurism with Isaac Arthur
Isaac Arthur

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Farm Small Farm Smart Daily
The Modern Grower Podcast Network

The 365 Days of Astronomy
365DaysOfAstronomy.org

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

Stuff To Blow Your Mind
iHeartPodcasts

The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Community discussion